Stock SNGX SOLIGENIX, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Estimates Revisions Soligenix, Inc.

Equities

SNGX

US8342236044

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-09-06 pm EDT 		5-day change 1st Jan Change
3.740 USD -9.88% Intraday chart for Soligenix, Inc. +6.86% -69.13%
Aug. 18 Transcript : Soligenix, Inc. - Special Call
Aug. 09 Soligenix, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 CI

Turnover - Evolution of Analysts' Estimates

Earnings Per Share (EPS) - Evolution of Analysts' Estimates

EBIT - Evolution of Analysts' Estimates

Add to a list
Add to a list

0 selected

To use this feature you must be a member
Log inSign up
 1m. EPS revision 1m. Revenue rev. 1y. EPS revision 1y. Revenue rev.
SOLIGENIX, INC. Stock Soligenix, Inc.
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
ARGENX SE Stock argenx SE
BIONTECH SE Stock BioNTech SE
BEIGENE, LTD. Stock BeiGene, Ltd.
GENMAB A/S Stock Genmab A/S
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
VAXCYTE, INC. Stock Vaxcyte, Inc.
 - -
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
Average
Weighted average by Cap.
See all sector revisions

Turnover

Estimates Revisions:

Earnings Per Share (EPS)

Estimates Revisions:

EBIT

Estimates Revisions:
  1. Stock Market
  2. Equities
  3. SNGX Stock
  4. Consensus Soligenix, Inc.
  5. Estimates Revisions
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW